ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250764.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.028278863	Resistant
ENSG00000250764.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.047160914	Sensitive